Porcine Enteropathy also known as ileitis in pigs , caused by Lawsonia intracellularis, is regarded as one of the major gut related health issues in pork production . Recent reports from national institutes for pharmaceutical products show that the annual amount of antibiotics against enteric diseases has increased over the last few years. Despite the ban of antimicrobial growth promoters in Europe since January 2006, the total amount of antibiotics used in pigs does not seem to be significantly reduced . This is contradictory to the demands of the consumers for a reduction in antibiotic use and the efforts to reduce the risk of antibiotic resistance. Recently several field studies have demonstrated that the use of Enterisd' ileitis (Boehringer lngelheim), a vaccine against ileitis can reduce the amount of antibiotics needed to prevent this disease. Additionally, vaccination can contribute to the overall reduction in use of antimicrobials on farms due to the higher health status of the farms . This oral vaccine is therefore a better alternative compared to antibiotics to prevent ileitis.
Introduction
In the past few years. the political situation on antimicrobial use in agriculture has changed. According to Wagstrom (2006) , ''the issue of antimicrobial use in food animals has in many ways moved out of the arena of scientific debate, and into the arena of consumer activism". This statement is based on the increasing presence of consumer groups on the internet and other open sources whtch question the way food producing animals are kept and raised . In Europe the ban on antimicrobial growth promoters (AGP) was started in Sweden and Denmark. The results were a drastic reduction in the overall tonnage in preventive antimicrobials, with a shift to more therapeutic use of antimtcrobials especially against enteric diseases. Since then , an increase in overall antibiotic usage has been reported in Denmark (Danmap 2005) . New problems have arisen with the link between Methicillin resistant Staphylococcus Aureus bacteria and swine production (Voss et al. 2005) . This problem has recently led to media coverage on national televiston in the Netherlands (Zembla 2006) . The use of vaccines in swine production has demonstrated over the years to be a good alternative for antibiotics for many diseases. In the year 2000 Boehringer lngelheim introduced Enterisol® ilettis, the first and only vaccine against ileitis caused by Lawsonia intrace/lularis, in the United States market. Since then. this vaccine has obtained marketing authorisation in most of the major pig producing countries throughout the world. In multiple trials the potential of Enterisol® ileitis for the reduction of antibtotics is investigated.
Study 1 -Mexico
Materials and methods This study was performed in northern Mexico. The production system was a multiple-site farm with 4000 sows. A total of 11 weekly production batches were evaluated; 7 control groups and 4 vacctnated groups. Production parameters were evaluated ustng standard statistical process control methods Criteria evaluated included: Average daily weight gain (ADWG), Feed efficiency (FE), Age at market, Weight at market, and Percent Culls. 
Results
Group 2: P1gs were g1ven a live vaccine against Lawsonia intracellu/aris (Enterisolt~ Ileitis), vaccinated at 5 weeks of age in the nursery by oral administration . Additionally a reduced pulse medication program was implemented:
• Tylosin 88 ppm/carbadox 55 ppm (25-40 kg) • Salinomyc1n 60 ppm (40-60 kg).
Vaccinated pigs grew nearly 15% faster than conventionally medicated p1gs (Table 1) . Other parameters showing improvement include mortality, market we1ght and age, and cull rates Feed efficiency rema1ned unchanged even with total antimicrobial use reduced by 35% in vaccmated p1gs. The h1story of enteric disease in the pigs mcluded all common pathogens seen in commercial p1g production -feed tnduced diarrhoea , gastnc ulcers , Salmonellosis, PCV-2, nonspec1 fic colitis, hemorrhagic bowel syndrome , tors1ons and endemic TGE (transmissible gastroenteritis virus) These conditions were diagnosed by routine pathology and histopathology Both the chrome/Proliferative Intestinal Adenomatosis (PIA) form and acute/Porcme Haemorrhagic Enteropathy (PHE) form are present m the system. Chronic diarrhoea h1stoncally began in commercial p1gs from 70 kg/150 lb to market, in the finishing barn. Hemorrhagic ileitis would occur 1n some groups of p1gs around the first marketing cut, and 1n replacement gilts after placement into sow farms, at around 33 weeks of age.
Control of Lawsonia intracellularis and other enteric diseases was attempted w1th feed grade medications In nursery p1gs, a system of carbadox, tiamulln/chlortetracycline and chlortetracycline alone was used. Th1s cont1nues today for 1ts broad spectrum respiratory and enteric benefit. Control of Lawsoma mtracel/ulans 1n finishing was based on several combinations of tylos1n , either at 100 ppm followed by 40 ppm, or 40 ppm continuously from 35 to 60 kg Breaks on th1s med1callon program occurred frequently, at an average of 70 or more enteric cases per month.
Water soluble tylosin was used as the first treatment option. When cases would not respond, water therapy was changed to tiamulin.
The goal for use of Enterisol® Ileitis was to reduce overall m-feed and water medication use, and, with Similar cost, Improve climcal control of disease m both h1gh value replacement gilts and fin1sh1ng p1gs. Replacement gilts were the first target for vaccination given the1r cost and the poor response to treatment of PHE cases. Vaccination of these animals began in 2001 . Follow1ng success in these animals, vacc1ne was tested m fin1sh1ng p1gs 1n 2002, with pigs vaccinated at 12-14 weeks of age, JUSt followmg placement 1nto finishing.
Vaccmahon has dramatically altered the feed medication program m finish1ng pigs and replacement gilts. Rout1ne use of both m-feed tylosin as well as growth promot1ng antibiotics has dropped to zero (see figure 2) . The numbers of groups needing treatment for diarrhoea of any k1nd has been reduced over 75% (<15 cases/month now) even with the removal of all in-feed medications (1 00 % reduction). This has made health management much Simpler at the field superv1sor level, as well as in the feed mill. This long1tud1nal study was executed in a farrow-to-fin1sh farm of 1 600 sows and 10 000 fattemng places The control group consisted of 16,032 pigs out of 32 fattening groups that were slaughtered between November 2004 and July 2005 The 13,848 slaughtered, Entensol 1le1t1s vacc1nated pigs belonged to 27 groups They reached slaughter between May and November 2005 All p1gs were housed under identical cond1t1ons The mon1tored parameters for the fatten1ng penod were ADWG (average da1ly we1ght gain), FC (Feed conversion ratio), mortality, and amount of ant1b1ot1c used aga1nst enteric diseases (AB use) The gross marg1n (GM) md1cates the possible economical benefit of the vaccination based on prior performance parameters Results Table 2 summarizes the results , which showed significant Improvement 1n all parameters. Not on ly a red uction of the overall level of antibiotic use is shown, but additionally to table 2 an increased level of control 1n p1g production in this farm is seen since vaccination started.
Furthermore, an economic benefit, expressed as Gross Margin of € 6.37 was generated . 
Conclusion
The results show a broad improvement 1n groups of vacc~nated p1gs Even with a reduction of antimicrobial use, p1gs grew faster and more consrstently.
These studies demonstrated that producers may have the option of eliminating fin1sh1ng dietary antimrcrobial use while reduc1ng 1nput costs and maintaining performance similar to or better than con tinuously medicated, non-vaccinated pigs. An overall reduction of 35 to 100 percent of In-feed ant1b10t1cs was realized . As restrictions on ant1mrcrob1al use continue to ~ncrease , pork producers will need more opt1ons for con trolling diseases like Ileitis which have traditionally accounted for much of the need for ant1mrcrobial use Use of Entensol ileitis to control ileitis is a b1olog1cally feas1ble, environmentally responsible and economically attractive alternative to cont~nuous feeding of antim1crob1als
